A mouse model utilising human transferrin to study protection againstNeisseria meningitidisserogroup B induced by outer membrane vesicle vaccination
Open Access
- 1 October 1999
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 26 (1) , 75-82
- https://doi.org/10.1111/j.1574-695x.1999.tb01374.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune responseVaccine, 1997
- Iron piracy: acquisition of transferrin‐bound iron by bacterial pathogensMolecular Microbiology, 1994
- Effect of outer membrane vesicle vaccine against group B meningococcal disease in NorwayThe Lancet, 1991
- Identification and characterization of the transferrin receptor from Neisseria meningitidisMolecular Microbiology, 1988
- Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.The Journal of Experimental Medicine, 1987
- Meningococcal Disease: Still with UsClinical Infectious Diseases, 1983
- Galactosamine-induced sensitization to the lethal effects of endotoxin.Proceedings of the National Academy of Sciences, 1979
- Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of AgeNew England Journal of Medicine, 1977
- Immunologic Response of Man to Group B Meningococcal Polysaccharide VaccinesThe Journal of Infectious Diseases, 1972
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969